We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 60

India to consider ban on importing animal-tested cosmetics
  • Shook Hardy & Bacon LLP
  • India, USA
  • January 9 2014

Following the June 2013 decision to prohibit the testing of domestically produced cosmetics and their ingredients on animals (details about which


Skin lightening products stir controversy worldwide
  • Shook Hardy & Bacon LLP
  • India, Japan, Malaysia, Philippines
  • June 26 2014

From allegations about mercury-laden skin lightening creams in the Philippines to new draft guidelines in India about advertising such products in a


EU agency will reinstate Ranbaxy’s GMP certificate
  • Shook Hardy & Bacon LLP
  • European Union, India
  • June 12 2014

The European Medicines Agency (EMA) has reportedly concluded its investigation of alleged non-compliance with good manufacturing practice (GMP) at


India to ban import of animal-tested cosmetics
  • Shook Hardy & Bacon LLP
  • India
  • June 6 2014

India's Ministry of Health & Family Welfare has reportedly introduced a draft rule, further amending the country's Drugs and Cosmetics rules, which


Indian lawyer seeks improvements to personal care product packaging
  • Shook Hardy & Bacon LLP
  • India
  • October 18 2013

In a petition filed before the Bombay High Court, activist-attorney Geetanjali Tapan Dutta has reportedly challenged the methods that multinational


FDA inspection finds CGMP violations at Bangalore facility
  • Shook Hardy & Bacon LLP
  • India, USA
  • June 26 2014

The U.S. Food and Drug Administration (FDA) has issued a warning letter to the president and CEO of Apotex, Inc., claiming that the agency's


India holds out among countries requiring transparency in industry payments
  • Shook Hardy & Bacon LLP
  • India
  • June 20 2013

According to a news source, while many countries have instituted disclosure obligations on health-care companies, often pharmaceutical and


UK and India to fund genomics and bioinformatics tech research
  • Shook Hardy & Bacon LLP
  • India, United Kingdom
  • April 4 2013

According to the U.K.'s Biotechnology and Biological Sciences Research Council (BBSRC), up to £10 million has been jointly pledged by the council and


Indian Supreme Court assesses care or cure properties of product in tariff dispute
  • Shook Hardy & Bacon LLP
  • India
  • August 29 2013

The Indian Supreme Court has affirmed lower tribunal rulings that Moisturex is a medicament used for its curative properties and, as such, is


Most ad complaints involving personalhealth care products upheld in India
  • Shook Hardy & Bacon LLP
  • India
  • July 10 2014

The most recent data released by the Advertising Standard Council of India (ASCI) show that the largest percentage of complaints upheld (95--46